Lobular Carcinoma In Situ (LCIS)
Epidemiology:
Common sites:
Gross features:
Histologic features:
Immunophenotype:
Marker: |
Sensitivity: |
Specificity: |
ER, PR |
Almost always (up to 90%) (pleomorphic
LCIS is more likely to be neg) |
|
e-cadherin (neg) |
80-90% of LCIS
and invasive lobular carcinoma |
|
HER2 (neg) |
Typically (pleomorphic
may be +) |
|
P53 (neg) |
Typically (pleomorphic
may be positive) |
|
Ki-67 |
Higher in
pleomorphic LCIS |
|
Molecular features:
Other features:
References: